Skip to main content

MoneyWorks4Me

Phaarmasia - Quaterly Results

13 Nov 2026 Evaluate
The sales moved down -62.06% to Rs. 62.79 millions for the September 2026 quarter as compared to Rs. 165.51 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2026 is Rs. -0.81 millions as compared to Net Profit of Rs. 17.35 millions of corresponding quarter ended September 2025Operating profit Margin for the quarter ended September 2026 slipped to -1.45% as compared to 17.53% of corresponding quarter ended September 2025


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 62.79 165.51 -62.06 145.62 234.25 -37.84 472.08 243.69 93.72
Other Income 3.52 1.40 151.43 6.53 4.55 43.52 9.61 7.46 28.82
PBIDT -1.45 17.53 -108.27 2.04 21.58 -90.55 28.36 -12.67 -323.84
Interest 0.04 0.01 300.00 0.15 0.28 -46.43 2.21 0.16 1281.25
PBDT -1.49 17.52 -108.50 1.89 21.30 -91.13 216.02 -12.83 -1783.71
Depreciation 0.52 0.55 -5.45 0.86 1.19 -27.73 2.14 3.20 -33.13
PBT -2.01 16.97 -111.84 1.03 20.11 -94.88 213.88 -16.03 -1434.25
TAX -1.20 -0.38 215.79 -1.55 0.05 -3200.00 38.15 -0.13 -29446.15
Deferred Tax -1.20 -0.38 215.79 -1.55 0.05 -3200.00 1.05 -0.13 -907.69
PAT -0.81 17.35 -104.67 2.58 20.06 -87.14 175.73 -15.90 -1205.22
Equity 68.27 68.27 0.00 68.27 68.27 0.00 68.27 68.27 0.00
PBIDTM(%) -2.31 10.59 -121.80 1.40 9.21 -84.79 6.01 -5.20 -215.55
Peers
Company Name CMP
Sun Pharma. Inds. 1894.90
Dr. Reddys Labs. 1391.10
Cipla 1409.75
Lupin 1985.85
Zydus Lifesciences 1192.00
View more..